Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Finasteride safely lowers DHT levels without affecting testosterone.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Long-term finasteride use doesn't change bone density or metabolism.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Some supplements and hormones can increase hair loss by raising DHT levels.

High doses of finasteride cause cell growth and tumors in mice.

Finasteride causes abnormal growth in male mice cells at high doses.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Traditional Chinese medicine techniques like catgut embedment, moxibustion, and bloodletting showed better results for treating hair loss than the drug finasteride.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

New treatments for male hypogonadism are effective and should be personalized.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.